2020
DOI: 10.1002/cld.935
|View full text |Cite
|
Sign up to set email alerts
|

Coagulation Homeostasis in Liver Disease

Abstract: http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/16-4-reading-caldwell a video presentation of this article http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/16-4-interview-caldwell-carlini an interview with the author

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
23
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(27 citation statements)
references
References 20 publications
1
23
0
Order By: Relevance
“…36,46 Forty percent of the dogs in our study had an increase in the acute phase protein and fibrinogen, and Increases in total PC activity in 87% of the dogs with GBM was an unexpected finding because decreases, rather than increases, in total PC activity, have been reported in dogs with hepatobiliary disorders. [17][18][19]46 The clinical relevance of these increases is unknown.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…36,46 Forty percent of the dogs in our study had an increase in the acute phase protein and fibrinogen, and Increases in total PC activity in 87% of the dogs with GBM was an unexpected finding because decreases, rather than increases, in total PC activity, have been reported in dogs with hepatobiliary disorders. [17][18][19]46 The clinical relevance of these increases is unknown.…”
Section: Discussionmentioning
confidence: 99%
“…Over the last decade, the complex alterations in coagulation that occur in human patients with hepatobiliary disease have been recognized. 17 , 18 , 19 These alterations involve changes in pro‐ and anticoagulants, as well as changes in factors involved in fibrinolysis. The net result is that human patients with liver disease have laboratory and clinical features of both hypo‐ and hypercoagulability.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, in some patients with compensated cirrhosis without ascites and morbid obesity, PCLB may be still the method of choice. If the sole indication for TJLB is "coagulopathy" based on INR or low platelet count, the concept of "rebalanced coagulation" needs to be considered [12,13]. In fact, most patients with "presumed coagulopathy" have normal values on more sophisticated coagulation tests, such as rotational thromboelastometry (ROTEM) [14].…”
Section: Dear Editormentioning
confidence: 99%